ABBVAbbVie Inc.vs its industry peers
A metric-by-metric comparison of AbbVie Inc. against its industry peers — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV본 종목 | $464.0B#2 | 74.2x#4 | — | 7.6x#5 | 8.6%#1 | -1.2%#4 | 24.6%#2 | — | 18.6%#2 | — | 24.5%#4 | 2.5%#3 |
| JNJ | $644.2B#1 | 31.0x#2 | 7.6x#3 | 6.8x#4 | 6.0%#2 | 90.6%#2 | 22.9%#3 | 31.5%#3 | 16.1%#3 | 6#2 | 54.4%#2 | 1.9%#5 |
| PFE | $156.7B#4 | 36.2x#3 | 1.8x#1 | 2.5x#1 | -1.6%#5 | -3.2%#5 | 16.3%#5 | 9.1%#4 | 6.9%#5 | — | 22.3%#5 | 6.2%#1 |
| MRK | $357.5B#3 | 115.9x#5 | 8.5x#4 | 5.5x#3 | 1.3%#3 | 6.6%#3 | 34.2%#1 | 43.5%#1 | 21.6%#1 | — | 82.8%#1 | 2.3%#4 |
| BMY | $129.9B#5 | 14.0x#1 | 5.8x#2 | 2.7x#2 | -0.2%#4 | 178.8%#1 | 21.8%#4 | 31.6%#2 | 14.0%#4 | 7#1 | 42.6%#3 | 3.9%#2 |
Peer set: Tickwind's hand-curated industry grouping. Values from SEC filings + delayed prices; ranks are sorted positions within this group only — descriptive, not a rating or advice. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice